Stephen W. Wright

2.4k total citations
107 papers, 1.6k citations indexed

About

Stephen W. Wright is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Stephen W. Wright has authored 107 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Organic Chemistry, 29 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Stephen W. Wright's work include Asymmetric Synthesis and Catalysis (10 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (8 papers) and Chemical Synthesis and Analysis (8 papers). Stephen W. Wright is often cited by papers focused on Asymmetric Synthesis and Catalysis (10 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (8 papers) and Chemical Synthesis and Analysis (8 papers). Stephen W. Wright collaborates with scholars based in United States, United Kingdom and China. Stephen W. Wright's co-authors include Lester D. McClure, David Hageman, E. J. Corey, Douglas G. Batt, Judith L. Treadway, Steven B. Coffey, John R. Cashman, Jeffery S. Thompson, Mark Nelson and Mark W. Bundesmann and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

Stephen W. Wright

103 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen W. Wright United States	20	978	557	132	131	105	107	1.6k
Hee‐Yoon Lee South Korea	26	1.2k 1.2×	708 1.3×	136 1.0×	215 1.6×	50 0.5×	94	1.9k
Scott S. Woodard United States	15	1.1k 1.1×	623 1.1×	281 2.1×	92 0.7×	55 0.5×	18	1.6k
Hisao Nemoto Japan	25	1.2k 1.2×	814 1.5×	159 1.2×	98 0.7×	135 1.3×	119	2.1k
Hiroko Masamune United States	10	1.5k 1.5×	673 1.2×	208 1.6×	266 2.0×	40 0.4×	18	2.1k
R. MCCAGUE United Kingdom	20	566 0.6×	564 1.0×	95 0.7×	109 0.8×	92 0.9×	54	1.4k
Gary M. Coppola United States	22	1.5k 1.6×	587 1.1×	134 1.0×	119 0.9×	52 0.5×	105	1.9k
Hans Peter Wessel Switzerland	20	1.0k 1.0×	695 1.2×	53 0.4×	66 0.5×	59 0.6×	72	1.4k
Edward D. Mihelich United States	27	1.3k 1.3×	820 1.5×	156 1.2×	228 1.7×	101 1.0×	46	2.2k
Paul Mosset France	21	716 0.7×	390 0.7×	147 1.1×	65 0.5×	59 0.6×	82	1.3k
Krishna C. Joshi India	19	714 0.7×	271 0.5×	112 0.8×	77 0.6×	82 0.8×	194	1.5k

Countries citing papers authored by Stephen W. Wright

Since Specialization

Citations

This map shows the geographic impact of Stephen W. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen W. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen W. Wright more than expected).

Fields of papers citing papers by Stephen W. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen W. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen W. Wright. The network helps show where Stephen W. Wright may publish in the future.

Co-authorship network of co-authors of Stephen W. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen W. Wright. A scholar is included among the top collaborators of Stephen W. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen W. Wright. Stephen W. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allais, Christophe, Agustin Casimiro‐Garcia, Rajesh Kumar, et al.. (2024). Early Process Development of Two Vanin-1 Inhibitors: Solid Form Challenges and Control of Ambident Reactivity. Organic Process Research & Development. 28(6). 2226–2236. 1 indexed citations

Wright, Stephen W., Kathleen A. Farley, Seungil Han, John D. Knafels, & Katherine L. Lee. (2024). In Retrospect: Root-Cause Analysis of Structure–Activity Relationships in IRAK4 Inhibitor Zimlovisertib (PF-06650833). ACS Medicinal Chemistry Letters. 15(4). 540–545. 2 indexed citations

Price, Paul J., et al.. (2024). Controlling enzyme hydrolysis of branched polymers synthesised using transfer-dominated branching radical telomerisation via telogen and taxogen selection. Communications Chemistry. 7(1). 197–197.

Dowty, Martin E., Ruolun Qiu, Alyssa Dantonio, et al.. (2024). The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite. Drug Metabolism and Disposition. 52(7). 690–702. 4 indexed citations

Gribble, Gordon W. & Stephen W. Wright. (2024). Synthesis of the indole alkaloid isolated from the marine sponge Halichondria melanodocia. Tetrahedron. 169. 134368–134368. 1 indexed citations

Wright, Stephen W., et al.. (2023). Exploring telogen chemical structure and reactivity when forming highly branched polyesters derived from ethylene glycol dimethacrylate homopolymerisation under transfer-dominated branching radical telomerisation (TBRT) conditions. Polymer Chemistry. 14(46). 5102–5114. 1 indexed citations

Choi, Chulho, Anthony Carlo, Ciarán N. Cronin, et al.. (2022). Synthesis of Deuterated Heterocycles with Me ₂ NCD(OMe) ₂ and Evaluation of the Products for Metabolism by Aldehyde Oxidase. ACS Medicinal Chemistry Letters. 13(2). 250–256. 4 indexed citations

Nanda, Sambit K., Francesco Marchesi, Marek Gierliński, et al.. (2019). Distinct signals and immune cells drive liver pathology and glomerulonephritis in ABIN1[D485N] mice. Life Science Alliance. 2(6). e201900533–e201900533. 13 indexed citations

Piotrowski, David W., Kentaro Futatsugi, M. F. Sammons, et al.. (2018). David W. Piotrowski, * Kentaro Futatsugi, Agustin Casimiro-Garcia, Liuqing Wei, Matthew F. Sammons, Michael Herr, Wenhua Jiao, Sophie Y. Lavergne, Steven B. Co ff ey, Stephen W. Wright, Kun Song, Paula M. Loria, Mary Ellen Banker, Donna N. Petersen, and J. Journal of Medicinal Chemistry. 3 indexed citations

10.

Tu, Meihua, Benjamin D. Stevens, Jianwei Bian, et al.. (2014). Identification of a novel conformationally constrained glucagon receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 24(3). 839–844. 16 indexed citations

11.

DeNinno, Michael P., Stephen W. Wright, John B. Etienne, et al.. (2012). Discovery of triazolopyrimidine-based PDE8B inhibitors: Exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes. Bioorganic & Medicinal Chemistry Letters. 22(17). 5721–5726. 22 indexed citations

12.

Filipski, Kevin J., Jianwei Bian, David C. Ebner, et al.. (2011). A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity. Bioorganic & Medicinal Chemistry Letters. 22(1). 415–420. 23 indexed citations

13.

DeNinno, Michael P., Stephen W. Wright, Michael Visser, et al.. (2011). 1,5-Substituted nipecotic amides: Selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability. Bioorganic & Medicinal Chemistry Letters. 21(10). 3095–3098. 22 indexed citations

14.

Wright, Stephen W., Mark Ammirati, Kim Andrews, et al.. (2007). (3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: Synthesis, in vitro, in vivo, and X-ray crystallographic characterization. Bioorganic & Medicinal Chemistry Letters. 17(20). 5638–5642. 13 indexed citations

15.

Wright, Stephen W., Virginia L. Rath, David Hageman, et al.. (2004). 5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization. Bioorganic & Medicinal Chemistry Letters. 15(2). 459–465. 26 indexed citations

16.

Wright, Stephen W., Anthony Carlo, Dennis E. Danley, et al.. (2003). 3-(2-Carboxy-ethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site. Bioorganic & Medicinal Chemistry Letters. 13(12). 2055–2058. 45 indexed citations

17.

Wright, Stephen W., David Hageman, Lester D. McClure, et al.. (2001). Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines. Bioorganic & Medicinal Chemistry Letters. 11(1). 17–21. 34 indexed citations

18.

Wright, Stephen W., Richard R. Harris, Janet S. Kerr, et al.. (1992). Synthesis, chemical, and biological properties of vinylogous hydroxamic acids: dual inhibitors of 5-lipoxygenase and IL-1 biosynthesis. Journal of Medicinal Chemistry. 35(22). 4061–4068. 18 indexed citations

19.

Wright, Stephen W., et al.. (1992). Novel 1-(pyridylphenyl)-1-phenyl-2-imidazolylethanols with topical antiinflammatory activity. Journal of Medicinal Chemistry. 35(17). 3148–3155. 21 indexed citations

20.

Wright, Stephen W. & R.R.M. Harman. (1983). Ethylenediamine and piperazine sensitivity.. BMJ. 287(6390). 463–464. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact